Australia | Apr 11 2006
In a press release this morning, Rockeby Biomed (RBY) has appointed distributors of its avian influenza test kits in Turkey, Palestine, Egypt, UAE and France.
The company has further signed a memorandum of understanding with Pacific Biotech of Thailand to license rights to manufacture the flu kits outside Thailand – with China, where there is a need for post-vaccination screening and surveillance, the main target.
An upfront fee and royalties to Rockeby will help facilitate local manufacture and sales in China, in turn reducing production costs. China is reported to have in excess of four billion chickens alone.
Rockeby sees this as an opportunity to increase margins. Global demand is increasing dramatically and the company is well placed to take advantage. Orders have also now come in from Thailand’s largest poultry producer. Romania has approved the kits.
The Animal Health Division of the World Health Organisation has also added Rockeby’s kit to its list of other bird flu tests. By the end of this year Rockeby expects official certification.
A clinical trial is underway in Hong Kong to comparatively evaluate such tests. Preliminary results are expected some time before June.

